Key Focus Areas

• Immuno-Oncology: AltruBio is primarily focused on developing innovative immunotherapies, which harness the power of the immune system to fight cancer.
• Targeted Therapies: They are also exploring targeted therapies that specifically attack cancer cells while minimizing harm to healthy tissues.

Key Technologies

• AltruBio may utilize various technologies in their research and development efforts, such as:
  • Antibody Engineering: Developing novel antibodies that can specifically target cancer cells.
  • Gene Therapy: Utilizing gene therapy approaches to modify the immune system to fight cancer.
  • Cellular Therapies: Developing therapies based on the use of immune cells, such as CAR T-cells.

Mission

AltruBio is committed to improving the lives of patients with cancer and other serious diseases by developing innovative and effective therapies.

Note: This is a general overview of AltruBio. For the most up-to-date information on their pipeline, clinical trials, and company developments, please refer to their official website and investor relations materials.